275 related articles for article (PubMed ID: 30378684)
1. Antiepileptic drug withdrawal in juvenile myoclonic epilepsy.
Syvertsen M; Fløgstad I; Enger U; Landmark CJ; Koht J
Acta Neurol Scand; 2019 Feb; 139(2):192-198. PubMed ID: 30378684
[TBL] [Abstract][Full Text] [Related]
2. Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study.
Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
Epilepsy Res; 2014 Dec; 108(10):1817-24. PubMed ID: 25443450
[TBL] [Abstract][Full Text] [Related]
3. Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy.
Healy L; Moran M; Singhal S; O'Donoghue MF; Alzoubidi R; Whitehouse WP
Seizure; 2018 Jul; 59():116-122. PubMed ID: 29807291
[TBL] [Abstract][Full Text] [Related]
4. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
[TBL] [Abstract][Full Text] [Related]
5. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
6. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years.
Syvertsen MR; Thuve S; Stordrange BS; Brodtkorb E
Seizure; 2014 May; 23(5):344-8. PubMed ID: 24512779
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Johannessen Landmark C; Fløgstad I; Baftiu A; Syvertsen M; Enger U; Koht J; Johannessen SI
Epilepsy Res; 2019 Sep; 155():106148. PubMed ID: 31195184
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types.
Kitazawa Y; Jin K; Kakisaka Y; Fujikawa M; Tanaka F; Nakasato N
Epilepsy Res; 2018 Aug; 144():20-24. PubMed ID: 29729533
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial complications in juvenile myoclonic epilepsy.
Syvertsen M; Selmer K; Enger U; Nakken KO; Pal DK; Smith A; Koht J
Epilepsy Behav; 2019 Jan; 90():122-128. PubMed ID: 30530133
[TBL] [Abstract][Full Text] [Related]
10. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
[TBL] [Abstract][Full Text] [Related]
11. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.
Geithner J; Schneider F; Wang Z; Berneiser J; Herzer R; Kessler C; Runge U
Epilepsia; 2012 Aug; 53(8):1379-86. PubMed ID: 22686598
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic analysis of juvenile myoclonic epilepsy in Indian families.
Jain S; Tripathi M; Srivastava AK; Narula A
Acta Neurol Scand; 2003 May; 107(5):356-62. PubMed ID: 12713528
[TBL] [Abstract][Full Text] [Related]
13. Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.
Cação G; Parra J; Mannan S; Sisodiya SM; Sander JW
Epilepsy Behav; 2018 May; 82():81-86. PubMed ID: 29602081
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
[TBL] [Abstract][Full Text] [Related]
15. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India.
Mehndiratta MM; Aggarwal P
Seizure; 2002 Oct; 11(7):431-6. PubMed ID: 12237068
[TBL] [Abstract][Full Text] [Related]
16. Topiramate monotherapy for juvenile myoclonic epilepsy.
Liu J; Wang LN; Wang YP
Cochrane Database Syst Rev; 2015 Dec; (12):CD010008. PubMed ID: 26695884
[TBL] [Abstract][Full Text] [Related]
17. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
[TBL] [Abstract][Full Text] [Related]
18. Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.
Welty TE
Paediatr Drugs; 2006; 8(5):303-10. PubMed ID: 17037947
[TBL] [Abstract][Full Text] [Related]
19. Generalized epilepsy syndromes and callosal thickness: Differential effects between patients with juvenile myoclonic epilepsy and those with generalized tonic-clonic seizures alone.
Anastasopoulou S; Kurth F; Luders E; Savic I
Epilepsy Res; 2017 Jan; 129():74-78. PubMed ID: 27923174
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome in adolescent-onset generalized genetic epilepsies.
Vorderwülbecke BJ; Kowski AB; Kirschbaum A; Merkle H; Senf P; Janz D; Holtkamp M
Epilepsia; 2017 Jul; 58(7):1244-1250. PubMed ID: 28464258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
